Quantcast
Last updated on April 18, 2014 at 6:54 EDT

Latest Heart valve Stories

2013-01-14 12:24:51

CHICAGO, Jan. 14, 2013 /PRNewswire/ -- Phoenix Cardiac Devices, Inc., a medical device company with a novel method of repairing leaky heart valves without open-heart surgery, has enrolled its first patient in a clinical trial aimed at achieving CE Mark approval in Europe. The trial will assess the safety and efficacy of the BACE(TM) device, an adjustable tension band that encircles the heart and supports the mitral valve leaflets so they close properly to prevent the back flow of blood into...

2013-01-14 02:30:03

BETHLEHEM, Pa., Jan. 14, 2013 /PRNewswire/ -- Micro Interventional Devices, Inc.(TM) (MID), an emerging cardiovascular medical device company, announced today it has secured $3.5 million of its expected $5 million Series B financing. The initial tranche was led by Originate Ventures with existing investor, Battelle Ventures, LP, also participating in the round. In conjunction with the financing Mike Gausling, Managing Partner of Originate Ventures, will join the MID Board of...

2013-01-07 08:28:10

WILMINGTON, Del. and MUNICH, Germany, Jan. 7, 2013 /PRNewswire/ -- JenaValve Technology, Inc., a privately-held, venture-backed developer, manufacturer and marketer of transcatheter-delivered aortic valve systems (TAVI) for the treatment of aortic valve disease, announced today that it has appointed veteran medical device executive Raymond W. Cohen as Executive Chairman of its Board of Directors. Mr. Cohen has worked as an executive in the medical device industry for more than 25 years and...

2012-12-20 08:27:08

CHICAGO, Dec. 20, 2012 /PRNewswire/ - The FDA 510(k) process is a complex process allowing Companies to apply or to not apply for a new 510(k) application. The Myxo File: Part I and Part II  just released through Kindle Direct Publishing will provide documents from the FDA compliance review and the letters sent by members of Congress and the White House including letters from The Honorable Senator Richard Lugar from Indiana and The Honorable Senator John McCain from Arizona on...

2012-10-26 00:32:15

Results of PARTNER Cohort B trial presented at TCT 2012 A study found that transcatheter aortic valve replacement (TAVR) yielded lower mortality rates after three years compared with medical therapy in patients deemed to be ineligible for conventional aortic valve surgery. Results of the PARTNER Cohort B trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the...

2012-10-22 07:30:02

BETHLEHEM, Pa., Oct. 22, 2012 /PRNewswire/ -- Micro Interventional Devices, Inc.(TM) (MID), an emerging cardiovascular medical device company, announced today that the first patient has been treated using its self-sealing, cardiac access and closure technology, Permaseal(TM). The patient is the first to be enrolled in the company's STASIS clinical trial that has commenced in Europe. The first STASIS case was performed by Principal Investigator Professor Dr. med. Rudiger Lange, Director of...

2012-10-19 19:21:25

More Patients Now Will Be Eligible for TAVR Procedure. CLEARWATER, Fla., Oct. 19, 2012 /PRNewswire-USNewswire/ -- Morton Plant Hospital is the first hospital in the Tampa Bay area to perform Transcatheter Aortic Valve Replacement (TAVR) by the transapical approach. Transapical TAVR is the latest FDA-approved treatment for people suffering from severe aortic stenosis. Aortic stenosis is a narrowing of the aortic valve of the heart, which causes the valve to fail to open and...

2012-10-18 07:25:34

TUCSON, Ariz., Oct. 18, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that San Raffaele Hospital in Milan, Italy, has discharged its first patient to receive the SynCardia temporary Total Artificial Heart. On Sept. 7, 55-year-old Marco Fumagalli left the hospital to wait for a matching donor heart at home using the Freedom® portable...

2012-10-10 03:21:09

NATICK, Mass., Oct. 10, 2012 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has enrolled the first patient in the REPRISE II clinical trial to evaluate the safety and performance of the Lotus(TM) Valve System in up to 120 patients with severe aortic valve disease. This international, multi-center study includes 15 sites in Australia, France, Germany and the United Kingdom. The Lotus Valve System is the first transcatheter aortic valve replacement (TAVR) device of its kind that is designed to...

2012-10-03 06:29:59

Prosthetics can be enlarged as children grow, reducing need for future replacement surgeries BOSTON, Oct. 3, 2012 /PRNewswire-USNewswire/ -- Surgeons at Boston Children's Hospital have successfully implanted a modified version of an expandable prosthetic heart valve in several children with mitral valve disease. Unlike traditional prosthetic valves that have a fixed diameter, the expandable valve can be enlarged as a child grows, thus potentially avoiding the repeat valve replacement...


Latest Heart valve Reference Libraries

Heart
2013-01-01 11:25:12

The heart is a part of the circulatory system, and is considered one of the most vital organs of the human body. It is about the size of a fist, has a mass of approximately 300 grams, and its main function is to contract and produce enough pressure to circulate blood throughout the body. The top of the heart where the veins and arteries all connect is called the base. The pointed lower tip of the heart is called the apex. The coronary sulcus is a deep groove that runs horizontally across the...

More Articles (1 articles) »